BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30518842)

  • 1. CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer.
    Ding L; Yang L; He Y; Zhu B; Ren F; Fan X; Wang Y; Li M; Li J; Kuang Y; Liu S; Zhai W; Ma D; Ju Y; Liu Q; Jia B; Sheng J; Chang Z
    Cell Death Dis; 2018 Dec; 9(12):1172. PubMed ID: 30518842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CREPT restrains gastric cancer growth by regulation of cycle arrest, migration and apoptosis via ROS-regulated p53 pathway.
    Sun M; Si G; Sun HS; Si FC
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1183-1190. PubMed ID: 29402413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA.
    Ji CM; Zhang X; Fang W; Meng L; Wei X; Lu C
    Exp Cell Res; 2021 Sep; 406(1):112741. PubMed ID: 34302858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
    Li J; Smith AR; Marquez RT; Li J; Li K; Lan L; Wu X; Zhao L; Ren F; Wang Y; Wang Y; Jia B; Xu L; Chang Z
    Mol Carcinog; 2018 Oct; 57(10):1408-1420. PubMed ID: 29938829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner.
    Zhai W; Ye X; Wang Y; Feng Y; Wang Y; Lin Y; Ding L; Yang L; Wang X; Kuang Y; Fu X; Eugene Chin Y; Jia B; Zhu B; Ren F; Chang Z
    Br J Cancer; 2021 Apr; 124(8):1437-1448. PubMed ID: 33531691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-139-5p inhibits the proliferation of gastric cancer cells by targeting Regulation of Nuclear Pre-mRNA Domain Containing 1B.
    Wenquan L; Hongqing X; Yuhua L; Lili W; Wang Z; Ziwei Z; Chuang W; Aizhen C; Xiaosong W; Bo W; Lin C
    Biochem Biophys Res Commun; 2020 Jun; 527(2):393-400. PubMed ID: 32327260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
    Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
    J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk1, but not Chk2, is responsible for G2/M phase arrest induced by diallyl disulfide in human gastric cancer BGC823 cells.
    Bo S; Hui H; Li W; Hui L; Hong X; Lin D; Dai WX; Wu YH; Ai XH; Hao J; Qi S
    Food Chem Toxicol; 2014 Jun; 68():61-70. PubMed ID: 24650757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic pre-B cell leukemia transcription factor interacting protein is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, migration, and invasion.
    Feng Y; Li L; Zhang X; Zhang Y; Liang Y; Lv J; Fan Z; Guo J; Hong T; Ji B; Ji Q; Mei G; Ding L; Zhang S; Xu X; Ye Q
    Cancer Sci; 2015 Oct; 106(10):1313-22. PubMed ID: 26211905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death.
    Li Z; Wang JW; Wang WZ; Zhi XF; Zhang Q; Li BW; Wang LJ; Xie KL; Tao JQ; Tang J; Wei S; Zhu Y; Xu H; Zhang DC; Yang L; Xu ZK
    Free Radic Biol Med; 2016 Oct; 99():593-607. PubMed ID: 27634171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CREPT regulated by miR-138 promotes breast cancer progression.
    Liang Z; Feng Q; Xu L; Li S; Zhou L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):263-269. PubMed ID: 28893536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RPRD1B promotes tumor growth by accelerating the cell cycle in endometrial cancer.
    Wang Y; Qiu H; Hu W; Li S; Yu J
    Oncol Rep; 2014 Mar; 31(3):1389-95. PubMed ID: 24452636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – a critical role of Cdk1 in mitotic entry.
    Chang WL; Yu CC; Chen CS; Guh JH
    Biochem Pharmacol; 2015 Mar; 94(1):12-21. PubMed ID: 25615907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy.
    Wang Y; Wang Z; Qi Z; Yin S; Zhang N; Liu Y; Liu M; Meng J; Zang R; Zhang Z; Yang G
    Mol Cancer; 2014 Apr; 13():94. PubMed ID: 24775809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.
    Liu W; Lu Y; Chai X; Liu X; Zhu T; Wu X; Fang Y; Liu X; Zhang X
    J Exp Clin Cancer Res; 2016 Nov; 35(1):183. PubMed ID: 27887633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CREPT and p15RS regulate cell proliferation and cycling in chicken DF-1 cells through the Wnt/β-catenin pathway.
    Jin K; Chen H; Zuo Q; Huang C; Zhao R; Yu X; Wang Y; Zhang Y; Chang Z; Li B
    J Cell Biochem; 2018 Jan; 119(1):1083-1092. PubMed ID: 28695988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer.
    Kim SJ; Lee HW; Baek JH; Cho YH; Kang HG; Jeong JS; Song J; Park HS; Chun KH
    Oncogene; 2016 Jan; 35(2):251-60. PubMed ID: 25823029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
    Pai HC; Kumar S; Shen CC; Liou JP; Pan SL; Teng CM
    PLoS One; 2015; 10(4):e0123819. PubMed ID: 25874627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.